Tarlatamab for SCLC Brain Metastases
NCT07402343
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer
Brain Metastases, Adult
Interventions
DRUG:
Tarlatamab
Sponsor
Maastricht University Medical Center
Collaborators
[object Object]
[object Object]
[object Object]